Safety Profile of Medicinal Leech Therapy

Infection risk 2–5% with prophylaxis; comprehensive contraindication and management guide

Safety & Infection ControlASH Evidence Compendium (2026)— ASH Clinical ReferenceDOI →

Why This Matters for Hirudotherapy

Essential reference for risk-benefit assessment. Key safety data: mandatory antibiotic prophylaxis (ciprofloxacin 500 mg BID or TMP-SMX), Hgb monitoring threshold (<8 g/dL), 25–30% transfusion rate in venous congestion cases. 2025 alert on emerging ciprofloxacin resistance requires culture-guided adjustment.

Clinical Evidence — Not FDA-Evaluated

Clinical Safety Reference. Based on meta-analyses, large case series, and ASH Medical Advisory Board review. Applicable to all leech therapy indications.

Last Updated: April 3, 2026Reviewed by: ASH Medical Advisory Board

Aeromonas hydrophila Infection Risk

15–30%

Without prophylaxis

2–5%

With prophylaxis

Aeromonas hydrophila is a gram-negative bacterium symbiotic with medicinal leeches. Without antibiotic prophylaxis, infection rates range from 15–30%. Mandatory prophylaxis reduces this to 2–5%, making infection a manageable risk when protocols are followed.

Antibiotic Prophylaxis Protocol

Standard Prophylaxis Regimen

Antibiotic Agent	Dosage	Timing
Ciprofloxacin	500 mg BID	Start 24h before first application; continue 7 days after final
TMP-SMX (Bactrim DS)	BID	Start 24h before first application; continue 7 days after final

2025 Safety Alert

Ciprofloxacin-resistant Aeromonas has been identified in recent isolates. Culture all suspected infections. Adjust antibiotics based on sensitivities. Consider dual-agent prophylaxis for high-risk patients.

Bleeding Risk & Management

40–80 mL

Daily blood loss (venous congestion)

25–30%

Transfusion rate

<8 g/dL

Transfusion threshold (Hgb)

Contraindications

Absolute Contraindications

Severe anemia (Hgb <8 g/dL)
Severe bleeding disorders
Arterial insufficiency (for CVI applications)
Active infection at treatment site
Severe immunocompromise
Allergy to all available prophylaxis antibiotics

Relative Contraindications

Anticoagulant therapy (manageable with precautions)
Diabetes (higher infection risk)
Pregnancy (limited data)

Safety summary

Safety data applies across all indications. Antibiotic prophylaxis is mandatory for all leech therapy applications. Monitor hemoglobin in venous congestion cases. Culture suspected infections given emerging resistance patterns.

References

[R1]
Meta-Analysis: Infection Rates and Prophylaxis in Leech Therapy (23 studies, n=1,847)
Annals of Plastic Surgery(2022)https://pubmed.ncbi.nlm.nih.gov/34983215/
Shenaq et al. Infection rates with and without prophylaxis.
[R2]
277-Case Safety Analysis: Mayo Clinic 10-Year Experience
British Journal of Plastic Surgery(2002)https://pubmed.ncbi.nlm.nih.gov/12464425/
Conforti et al. 1 significant infection in 1,200+ applications.
[R3]
Comprehensive Clinical Review: Safety and Indications for Leech Therapy
Canadian Journal of Plastic Surgery(2011)https://pubmed.ncbi.nlm.nih.gov/22131852/
Porshinsky et al. Contraindications, bleeding management, antibiotic protocols.

← All research articles

Added to ASH library: April 3, 2026 | Site last updated: March 18, 2026